Another study conducted by researchers at St Barnabas Medical Center in New Jersey and published on the medical website medRxiv concluded that hydroxychloroquine, a commonly used malaria drug, can increase a person’s chances of surviving COVID by 200%.
The study involved 255 people who were severely ill from the virus and on ventilators.
The researchers concluded:
‘We found that when the cumulative doses of two drugs, HCQ and AZM, were above a certain level, patients had a survival rate 2.9 times the other patients.’
READ: Was Trump right about hydroxychloroquine all along? New study shows drug touted by former president can increase COVID survival rates by 200%
It is yet another example, on how quickly COVID and the lockdowns became political. When former US President Trump’s suggested that hydroxychloroquine was effective in fighting the virus, the condemnation by the mainstream media and those on the political left was almost unanimous.
I said it was almost unanimous because some Democrats were actually thanking Trump for recommending the drug:
READ: Democratic NY City councilman says hydroxychloroquine saved his life, thanks Trump for advocating drug
READ: Democratic state lawmaker says Trump touting hydroxychloroquine as coronavirus treatment saved her life
Nevertheless, Twitter limited access to the account of Donald Trump Jr after he posted a video of doctors recommending hydroxychloroquine for COVID. The social media giant’s censors, posing as medical experts, accused him of spreading misleading information.
Others were suggesting that the President should be dragged before the court in Hague for crimes against humanity for simply recommending the safe and proven Malaria drug.
Of course, this is not the first study to show the effectiveness of hydroxychloroquine in the treatment of COVID.
READ: Coronavirus deaths 75% lower in nations using hydroxychloroquine
READ: New studies show risk of COVID-19 hospitalization and death decreases with hydroxychloroquine use
READ Treatment with Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients, Henry Ford Health System Study Shows